Pharmacokinetic interactions of paclitaxel, docetaxel and their vehicles with doxorubicin
- 1 April 1999
- journal article
- research article
- Published by Elsevier in Annals of Oncology
- Vol. 10 (4) , 391-395
- https://doi.org/10.1023/a:1008309916974
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- The TaxoidsDrugs, 1998
- Review of recent trials of chemotherapy for advanced breast cancer: Studies excluding taxanesEuropean Journal Of Cancer, 1997
- The transport and binding of taxolGeneral Pharmacology: The Vascular System, 1997
- Human pharmacokinetic characterization and in vitro study of the interaction between doxorubicin and paclitaxel in patients with breast cancer.Journal of Clinical Oncology, 1997
- Paclitaxel induces significant changes in epidoxorubicin distribution in miceAnnals of Oncology, 1996
- Cremophor Pharmacokinetics in Patients Receiving 3-, 6-, and 24-Hour Infusions of PaclitaxelJNCI Journal of the National Cancer Institute, 1996
- Combined doxorubicin and paclitaxel in advanced breast cancer: Effective and cardiotoxicAnnals of Oncology, 1996
- Paclitaxel by 3-hour infusion in combination with bolus doxorubicin in women with untreated metastatic breast cancer: high antitumor efficacy and cardiac effects in a dose-finding and sequence-finding study.Journal of Clinical Oncology, 1995
- P-glycoprotein, multidrug resistance and tumor progressionCancer and Metastasis Reviews, 1994
- BIOCHEMISTRY OF MULTIDRUG RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTERAnnual Review of Biochemistry, 1993